These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 1316059)
21. Comparison of the safety and efficacy of lomefloxacin and amoxicillin in the treatment of acute exacerbations of chronic bronchitis: Results from a Latin American multicenter study. Saenz-Aguirre C; Amaya-Tapia G; Andrade-Villanueva J; Perez-Gomez R; Morfin-Otero R; Rodriguez-Noriega E Int J Antimicrob Agents; 1992 Dec; 2(1):49-54. PubMed ID: 18611519 [TBL] [Abstract][Full Text] [Related]
22. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin. Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620 [TBL] [Abstract][Full Text] [Related]
23. Infection in the elderly: studies with lomefloxacin. Crome P; Bruce-Jones P Am J Med; 1992 Apr; 92(4A):126S-129S. PubMed ID: 1316062 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: results from a multicenter study. Andrade-Villanueva J; Flores-Gaxiola A; Lopez-Guillen P; Aguirre-Avalos G; Morfin-Otero R; Rodriguez-Noriega E Am J Med; 1992 Apr; 92(4A):71S-74S. PubMed ID: 1316074 [TBL] [Abstract][Full Text] [Related]
25. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study. Bandak SI; Bolzon LD; Turnak MR; Johns D; Henle SK; Allen BS Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750 [TBL] [Abstract][Full Text] [Related]
27. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis. Dere WH; Farlow D; Therasse DG; Ruoff GE Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625 [TBL] [Abstract][Full Text] [Related]
28. Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%. Tabbara KF; El-Sheikh HF; Islam SM; Hammouda E Eur J Ophthalmol; 1999; 9(4):269-75. PubMed ID: 10651190 [TBL] [Abstract][Full Text] [Related]
29. Oral cefaclor for treatment of bronchitis--a comparative double-blind study versus amoxycillin. Beumer HM; Veldkamp J Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):113-7. PubMed ID: 7068283 [TBL] [Abstract][Full Text] [Related]
30. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group. O'Doherty B; Daniel R Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290 [TBL] [Abstract][Full Text] [Related]
31. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Wilson R; Schentag JJ; Ball P; Mandell L; Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408 [TBL] [Abstract][Full Text] [Related]
32. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis. Grassi C; Salvatori E; Rosignoli MT; Dionisio P; Respiration; 2002; 69(3):217-22. PubMed ID: 12097764 [TBL] [Abstract][Full Text] [Related]
33. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis. Grossman RF Postgrad Med J; 1992; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616 [TBL] [Abstract][Full Text] [Related]
34. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study. Allegra L; Konietzko N; Leophonte P; Hosie J; Pauwels R; Guyen JN; Petitpretz P J Antimicrob Chemother; 1996 May; 37 Suppl A():93-104. PubMed ID: 8737129 [TBL] [Abstract][Full Text] [Related]
35. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group. File T; Schlemmer B; Garau J; Lode H; Lynch S; Young C J Chemother; 2000 Aug; 12(4):314-25. PubMed ID: 10949981 [TBL] [Abstract][Full Text] [Related]
36. A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis. Mouton Y; Ajana F; Chidiac C; Capron MH; Home P; Masquelier AM Am J Med; 1992 Apr; 92(4A):87S-90S. PubMed ID: 1316078 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia. Pryka R; Kowalsky S; Haverstock D Clin Ther; 1998; 20(1):141-55. PubMed ID: 9522111 [TBL] [Abstract][Full Text] [Related]
38. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. Wilson R; Kubin R; Ballin I; Deppermann KM; Bassaris HP; Leophonte P; Schreurs AJ; Torres A; Sommerauer B J Antimicrob Chemother; 1999 Oct; 44(4):501-13. PubMed ID: 10588312 [TBL] [Abstract][Full Text] [Related]
39. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group. Neringer R; Forsgren A; Hansson C; Ode B Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623 [TBL] [Abstract][Full Text] [Related]
40. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections. Dark D Am J Med; 1991 Sep; 91(3A):31S-35S. PubMed ID: 1656740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]